You can find the annual or quarterly income statement of Kairos Pharma Ltd here for insights into the performance and operational efficiency of Kairos Pharma Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Total revenue

--0.00

Revenue

--0.00

Operating expenses

256.40%1.36M

520.72%1.38M

341.11%1.27M

32.78%1.45M

33.45%383.00K

4.72%222.00K

127.78%287.00K

505.00%1.09M

131.45%287.00K

76.67%212.00K

-14.29%126.00K

--180.00K

--124.00K

--120.00K

--147.00K

R&D expenses

4242.86%608.00K

687.30%496.00K

198.79%493.00K

2357.14%172.00K

-57.58%14.00K

75.00%63.00K

2650.00%165.00K

-85.42%7.00K

--33.00K

500.00%36.00K

-81.82%6.00K

--48.00K

--0.00

--6.00K

--33.00K

Depreciation, depletion, and amortization

0.00%40.00K

--40.00K

Operating profit

-256.40%-1.36M

-520.72%-1.38M

-341.11%-1.27M

-32.78%-1.45M

-33.45%-383.00K

-4.72%-222.00K

-127.78%-287.00K

-505.00%-1.09M

-131.45%-287.00K

-76.67%-212.00K

14.29%-126.00K

---180.00K

---124.00K

---120.00K

---147.00K

Net non-operating interest income (expenses)

Non-operating interest income

--37.00K

--34.00K

--4.00K

----

Non-operating interest expense

----

-100.00%0.00

----

-100.00%0.00

408.00%127.00K

29.17%31.00K

80.00%36.00K

81.25%29.00K

-77.27%25.00K

-90.94%24.00K

-70.59%20.00K

--16.00K

--110.00K

--265.00K

--68.00K

Gains from sale of securities

----

---133.00K

---537.00K

----

--0.00

100.00%0.00

--0.00

---20.00K

Special income (expenses)

---70.00K

---78.00K

----

--599.00K

----

Income before tax

-33.52%-1.40M

-462.06%-1.42M

-290.71%-1.26M

12.34%-980.00K

-235.58%-1.05M

-7.20%-253.00K

-121.23%-323.00K

-470.41%-1.12M

-33.33%-312.00K

38.70%-236.00K

37.87%-146.00K

---196.00K

---234.00K

---385.00K

---235.00K

Income after tax

-33.52%-1.40M

-462.06%-1.42M

-290.71%-1.26M

12.34%-980.00K

-235.58%-1.05M

-7.20%-253.00K

-121.23%-323.00K

-470.41%-1.12M

-33.33%-312.00K

38.70%-236.00K

37.87%-146.00K

---196.00K

---234.00K

---385.00K

---235.00K

Net income from continuous operations

-33.52%-1.40M

-462.06%-1.42M

-290.71%-1.26M

12.34%-980.00K

-235.58%-1.05M

-7.20%-253.00K

-121.23%-323.00K

-470.41%-1.12M

-33.33%-312.00K

38.70%-236.00K

37.87%-146.00K

---196.00K

---234.00K

---385.00K

---235.00K

Net income attributable to controlling interests

-33.52%-1.40M

-462.06%-1.42M

-290.71%-1.26M

12.34%-980.00K

-235.58%-1.05M

-7.20%-253.00K

-121.23%-323.00K

-470.41%-1.12M

-33.33%-312.00K

38.70%-236.00K

37.87%-146.00K

---196.00K

---234.00K

---385.00K

---235.00K

Net income attributable to common shareholders

-33.52%-1.40M

-462.06%-1.42M

-290.71%-1.26M

12.34%-980.00K

-235.58%-1.05M

-7.20%-253.00K

-121.23%-323.00K

-470.41%-1.12M

-33.33%-312.00K

38.70%-236.00K

37.87%-146.00K

---196.00K

---234.00K

---385.00K

---235.00K

Basic earnings per share

27.90%-0.07

-319.34%-0.08

-216.06%-0.08

15.91%-0.07

-294.94%-0.10

-7.18%-0.02

-121.20%-0.03

-470.51%-0.09

-33.37%-0.02

38.69%-0.02

37.87%-0.01

---0.02

---0.03

---0.02

Diluted earnings per share

27.90%-0.07

-319.34%-0.08

-216.06%-0.08

15.91%-0.07

-294.94%-0.10

-7.18%-0.02

-121.20%-0.03

-470.51%-0.09

-33.37%-0.02

38.69%-0.02

37.87%-0.01

---0.02

---0.03

---0.02

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

